ACIPHEX® (rabeprazole sodium) Approved For Treatment Of Symptomatic Gastroesophageal Reflux Disease (GERD)
Proton Pump Inhibitor (PPI) Approved for Daytime and Nighttime Heartburn Relief
18-Feb-2002 -
Teaneck, NJ and Titusville, NJ (February 15, 2002) -- Eisai Inc. and Janssen Pharmaceutica Inc. announced today that the U.S. Food and Drug Administration has approved the expanded use of the PPI, ACIPHEX® (rabeprazole sodium), to include the treatment of daytime and nighttime heartburn and other ...
acids
clinical trials
diarrhea
+11